{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:14:59Z","timestamp":1790090099685,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Anadolu University Scientific Research Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejpb.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T13:30:25Z","timestamp":1477402225000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer"],"prefix":"10.1016","volume":"109","author":[{"given":"G\u00fclay","family":"B\u00fcy\u00fckk\u00f6ro\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behiye","family":"\u015eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Yenilmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Yazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0005","first-page":"48","article-title":"Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania","volume":"11","author":"Urasa","year":"2011","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0010","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.febslet.2014.02.041","article-title":"RASSF tumor suppressor gene family: biological functions and regulation","volume":"588","author":"Volodko","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2016.10.017_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.07.016","article-title":"Cationic lipids and polymers mediated vectors for delivery of siRNA","volume":"123","author":"Zhang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2014.08.011","article-title":"Delivery systems for sirna drug development in cancer therapy","volume":"10","author":"Xu","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2016.10.017_b0030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.addr.2009.03.003","article-title":"Lipid-based systemic delivery of siRNA","volume":"61","author":"Tseng","year":"2009","journal-title":"Adv. Drug Deliver. Rev."},{"issue":"18","key":"10.1016\/j.ejpb.2016.10.017_b0035","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4161\/cc.5.18.3192","article-title":"Delivery of RNA interference","volume":"5","author":"Li","year":"2006","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.ejpb.2016.10.017_b0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2007.08.189","article-title":"Chemically modified siRNA prolonged RNA interference in renal disease","volume":"363","author":"Takabatake","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2016.10.017_b0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2007.05.021","article-title":"Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery","volume":"121","author":"Gary","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","article-title":"Drug delivery of siRNA therapeutics: potentials and limits of nanosystems","volume":"5","author":"Reischl","year":"2009","journal-title":"Nanomed. Nanotech. Biol. Med."},{"issue":"9","key":"10.1016\/j.ejpb.2016.10.017_b0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.visres.2006.11.026","article-title":"Suppression of mouse rhodopsin expression in vivo by AAV Mediated siRNA delivery","volume":"47","author":"Gorbatyuk","year":"2007","journal-title":"Vision. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0060","first-page":"21","article-title":"Knockdown of PLK1 mRNA by special siRNA","volume":"28","author":"Chen","year":"2006","journal-title":"Yi Chuan"},{"issue":"4","key":"10.1016\/j.ejpb.2016.10.017_b0065","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.bbrc.2003.11.057","article-title":"Cationic liposome-mediated delivery of siRNAs in adult mice","volume":"312","author":"Sioud","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.ejpb.2016.10.017_b0070","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1021\/bi062138l","article-title":"Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA","volume":"46","author":"Bouxsein","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/nass\/49.1.17","article-title":"Smart polymeric micelles as nanocarriers for oligonucleotides and siRNA delivery","volume":"49","author":"Kataoka","year":"2005","journal-title":"Nucleic Acids Symp. Ser."},{"issue":"2","key":"10.1016\/j.ejpb.2016.10.017_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2006.07.021","article-title":"Development and characterisation of chitosan nanoparticles for siRNA delivery","volume":"115","author":"Katas","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1040-8428(03)00131-8","article-title":"New drugs in the treatment of recurrent or metastatic cervical cancer","volume":"48","author":"Savaese","year":"2003","journal-title":"Crit. Rev. Oncol. Hemat."},{"key":"10.1016\/j.ejpb.2016.10.017_b0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.027","article-title":"A folate receptor-targeted liposomal formulation for paclitaxel","volume":"316","author":"Wu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jconrel.2007.11.018","article-title":"Injectable chitosan hydrogels for localised cancer therapy","volume":"126","author":"Thu","year":"2008","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2016.10.017_b0100","first-page":"405","article-title":"Solid lipid nanoparticles: a novel carrier for cancer therapy","volume":"3","author":"Chimmiri","year":"2012","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejpb.2004.03.026","article-title":"Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line","volume":"58","author":"Serpea","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0110","first-page":"59","article-title":"Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential","volume":"25","author":"Shah","year":"2014","journal-title":"J. Phys. Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actbio.2016.04.026","article-title":"Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy","volume":"38","author":"Banerjee","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2016.10.017_b0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2011.11.002","article-title":"Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA","volume":"80","author":"Yu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2005.03.032","article-title":"Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir","volume":"106","author":"Paveli\u0107","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0135","first-page":"3","article-title":"Vaginal drug delivery systems: a review of current status","volume":"10","author":"Dobaria","year":"2007","journal-title":"East Cent Afr. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2016.10.017_b0140","first-page":"1033","article-title":"A review on novelty and potentiality of vaginal drug delivery","volume":"3","author":"Choudhury","year":"2011","journal-title":"Int. J. Pharm.Tech. Res."},{"key":"10.1016\/j.ejpb.2016.10.017_b0145","series-title":"Practical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal Products","first-page":"190","article-title":"Rectal and vaginal","author":"Haas","year":"2015"},{"key":"10.1016\/j.ejpb.2016.10.017_b0150","first-page":"698","article-title":"Solid lipid and chitosan particulate systems for delivery of siRNA","volume":"8","author":"\u015eenel","year":"2015","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.10.017_b0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2007.09.038","article-title":"Multifunctional poly (D, l-lactide-coglycolide)\/montmorillonite (PLGA\/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer","volume":"29","author":"Sun","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.10.017_b0160","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3906\/kim-1412-40","article-title":"Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAP\u00ae for DNA delivery","volume":"39","author":"B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2015","journal-title":"Turk. J. Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2016.10.017_b0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/nat.2011.0293","article-title":"Polymers in small-interfering RNA delivery","volume":"21","author":"Singha","year":"2011","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ejpb.2016.10.017_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity tests","volume":"63","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejpb.2016.10.017_b0175","first-page":"1610","article-title":"Microvolume protein concentration determination using the NanoDrop 2000c spectrophotometer","volume":"33","author":"Desjardins","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejpb.2016.10.017_b0180","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ejpb.2007.12.007","article-title":"Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters","volume":"69","author":"Neves","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.ejpb.2016.10.017_b0190","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2016.10.017_b0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"Neves","year":"2015","journal-title":"Adv. Drug Deliver. Rev."},{"issue":"5","key":"10.1016\/j.ejpb.2016.10.017_b0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.apsb.2013.08.001","article-title":"Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain","volume":"3","author":"Prabhakar","year":"2013","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ejpb.2016.10.017_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2016.10.017_b0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Soutoa","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2010.01.030","article-title":"PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles","volume":"389","author":"Vighi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejps.2013.02.011","article-title":"DNA delivery via cationic solid lipid nanoparticles (SLNs)","volume":"49","author":"Carrillo","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcis.2015.01.040","article-title":"Studying bubble\u2013particle interactions by zeta potential distribution analysis","volume":"449","author":"Wu","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2016.10.017_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejpb.2016.10.017_b0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2015.11.007","article-title":"PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity","volume":"99","author":"Belletti","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0240","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/elps.200800528","article-title":"Dielectrophoretic detection and quantification of hybridized DNA molecules on nano-genetic particles","volume":"29","author":"Gagnon","year":"2008","journal-title":"Electrophoresis"},{"issue":"5","key":"10.1016\/j.ejpb.2016.10.017_b0245","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.7314\/APJCP.2014.15.5.2335","article-title":"Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells","volume":"15","author":"Yadav","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejpb.2016.10.017_b0250","first-page":"379","article-title":"Poly(D,l-lactide-coglycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency","volume":"85","author":"Gvili","year":"2006","journal-title":"Biopolymers"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2016.10.017_b0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejpb.2016.10.017_b0260","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1096\/fj.09-142398","article-title":"Comprehensive analysis of sequence-specific stability of siRNA","volume":"24","author":"Hong","year":"2010","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.ejpb.2016.10.017_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0097797","article-title":"Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery","volume":"9","author":"Jafari","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.10.017_b0270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2015.10.015","article-title":"Nanoparticle-siRNA: a potential cancer therapy?","volume":"98","author":"Young","year":"2016","journal-title":"Crit. Rev. Oncol. Hemat."},{"key":"10.1016\/j.ejpb.2016.10.017_b0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chemphyslip.2010.01.001","article-title":"Cationic lipid-mediated nucleic acid delivery: beyond being cationic","volume":"163","author":"Rao","year":"2010","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2016.10.017_b0280","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nantod.2012.06.013","article-title":"Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance","volume":"7","author":"Creixell","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.ejpb.2016.10.017_b0290","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biotechadv.2014.10.011","article-title":"Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer","volume":"33","author":"Wang","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejpb.2016.10.017_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.03.012","article-title":"Gels as vaginal drug delivery systems","volume":"318","author":"das Neves","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.017_b0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","article-title":"Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA","volume":"236","author":"Furst","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.017_b0305","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejpb.2009.06.005","article-title":"In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulation","volume":"73","author":"Poelvoorde","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T04:23:40Z","timestamp":1536294220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116307329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":61,"alternative-id":["S0939641116307329"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.017","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}